サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768809

キャピラリー電気泳動の世界市場

Capillary Electrophoresis

出版日
ページ情報
英文 153 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
キャピラリー電気泳動の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 153 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

キャピラリー電気泳動の世界市場は2030年までに15億米ドルに達する

2024年に11億米ドルと推定されたキャピラリー電気泳動の世界市場は、2030年には15億米ドルに達し、分析期間2024-2030年のCAGRは6.0％で成長すると予測されます。本レポートで分析したセグメントの1つである学術機関＆CROは、CAGR 6.4％を記録し、分析期間終了時には7億4,720万米ドルに達すると予測されます。製薬＆バイオテクノロジー企業セグメントの成長率は、分析期間中CAGR 5.8％と推定されます。

米国市場は推定2億7,390万米ドル、中国はCAGR9.5%で成長予測

米国のキャピラリー電気泳動市場は、2024年に2億7,390万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.5％を辿り、2030年までに3億6,430万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と4.6%と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界のキャピラリー電気泳動市場- 主要動向と促進要因のまとめ

キャピラリー電気泳動が現代の分析化学において重要なツールである理由とは？

キャピラリー電気泳動（CE）は、電解質溶液を満たした細いキャピラリー管に電界をかけ、イオン種をサイズ対電荷比に基づいて分離する強力な分析技術です。この方法は電気泳動の原理を利用しており、電荷を帯びた分子は、その電荷、サイズ、媒体の粘度に応じて異なる速度でキャピラリー内を移動します。CEは、タンパク質、核酸、ペプチドなどの生体分子や、医薬品や代謝物のような低分子の分離・分析に広く利用されています。CEで使用される細いキャピラリーは、通常フューズドシリカ製で、高電圧でも効率的な熱放散が可能なため、従来のゲル電気泳動に比べてピークがシャープになり、分離能が向上します。さらに、キャピラリーゾーン電気泳動（CZE）、ミセル動電クロマトグラフィー（MEKC）、キャピラリーゲル電気泳動（CGE）などの様々なCEモードにより、特定の分析ニーズに合わせた幅広い応用が可能です。高い分離効率、必要最小限のサンプル量、迅速な分析時間により、CEは研究および臨床の両分野で理想的なツールとなっています。特に製薬やバイオテクノロジー業界では、純度試験、品質管理、複雑な生物学的サンプルの分析に利用されています。このように、キャピラリー電気泳動は、様々な分野で正確で再現性のある結果を提供する、現代分析化学の基礎技術となっています。

キャピラリー電気泳動の可能性を再定義する技術的ブレークスルーとは？

技術の進歩は、キャピラリー電気泳動の能力とアプリケーションを大幅に拡大し、その感度、自動化、他の分析法との統合を強化しました。最もインパクトのある開発のひとつは、CEと質量分析（CE-MS）の結合です。これは、CEの高分解能分離能力とMSの質量ベースの同定能力を組み合わせたものです。このハイブリッド技術は、タンパク質やオリゴヌクレオチドのような複雑な生体分子の詳細な構造解明を可能にし、1回の分析で定量的データと定性的データの両方を提供します。レーザー誘起蛍光（LIF）やUV-vis検出器などの高度な検出システムの使用により、CEの感度も向上し、低存在量の分析物を高い特異性で検出できるようになりました。自動化も技術革新の重要な分野であり、最新のCE装置では、サンプルハンドリング、キャピラリー洗浄、データ取得が自動化されているため、人為的ミスのリスクが軽減され、スループットが向上しています。さらに、マイクロチップを用いたCE（MCE）の開発により、小型化とハイスループット分析の新たな道が開かれました。これらのマイクロ流体プラットフォームは、しばしば"lab-on-a-chip "システムと呼ばれ、CEを小規模なチップ上に統合することで、試薬の消費量とサンプル量を最小限に抑えながら、迅速かつ並列的な分析を可能にします。もう一つの大きな進歩は、コーティングされたキャピラリーの使用と、分析対象物の吸着やピーク幅の拡大といった問題を最小限に抑える新しい電解質処方です。さらに、エナンチオマー分析のためのキラルCEや、生体分子の相互作用を研究するためのアフィニティーCEなど、新しい分離モードの出現は、CEの応用範囲を広げました。このような技術的強化により、CEは、製薬研究から環境試験に至るまで、幅広い科学分野において汎用性の高い高性能ツールへと変貌を遂げました。

研究の優先順位の変化と業界の要求は、キャピラリー電気泳動市場にどのような影響を与えていますか？

キャピラリー電気泳動市場は、研究の優先順位の変化、規制当局の要求の高まり、学術界と産業界の両方における高分解能、高スループット分析技術へのニーズの高まりによって形成されています。プロテオミクス、ゲノミクス、メタボロミクス研究の拡大により、複雑な生物学的サンプルの分離・分析ツールとしてのCEに対する需要が急増しています。研究者は、高感度と特異性、微量サンプルの分離能力を提供する技術を必要としており、CEはタンパク質アイソフォーム、DNA断片、微量代謝物の分析に適した選択肢となっています。製薬業界では、医薬品の純度を正確に評価し、キラル化合物を分離し、不純物をプロファイリングできるCEが脚光を浴びています。これらは、FDAやEMAなどの機関が定める厳しい規制要件に準拠するための重要なパラメータです。さらに、モノクローナル抗体や遺伝子治療薬などのバイオ医薬品が重視されるようになったことで、生物製剤の特性評価や製品の品質と一貫性を確保するためのCEへの関心が高まっています。もう一つの促進要因は、自動化されたワークフローにシームレスに統合でき、市場投入までの時間を短縮し、研究室の生産性を向上させる、堅牢で再現性の高い分析手法の必要性です。臨床診断におけるCEの採用も増加しており、特にヘモグロビン変異体の分析や遺伝性疾患の検出において、従来の研究用途を超えた役割の拡大を反映しています。さらに、グリーンケミストリーや持続可能な研究室運営の動向は、従来のクロマトグラフィー法に比べて有機溶媒の使用量や廃棄物の発生量が少ないCEを後押ししています。業界のニーズがより正確で迅速、かつ環境に優しい分析ソリューションへと進化する中、キャピラリー電気泳動はこれらの要件に合致する重要な技術として台頭してきています。

キャピラリー電気泳動市場の急成長を促進する主な要因は？

キャピラリー電気泳動市場の成長は、高分解能分析技術に対する需要の増加、CE-MS技術の進歩、製薬・バイオテクノロジー分野における効率的な生体分子特性解析のニーズの高まりなど、いくつかの重要な要因によって牽引されています。プロテオミクス、ゲノミクス、個別化医療への注目の高まりは、複雑な生物学的混合物を高精度で分離・同定できる高度な分析ツールの必要性に拍車をかけています。このためCEは、最先端の研究や臨床応用に携わるラボにとって不可欠な技術として位置づけられています。CEと質量分析計（CE-MS）の統合は、医薬品開発、バイオマーカー探索、法医学分析において非常に貴重な、感度の向上と包括的な分子プロファイリング能力を提供し、大きな成長のきっかけとなりました。さらに、規制当局がCEを品質管理やコンプライアンス検査、特に医薬品の純度や安定性を保証するために使用する製薬業界で推奨するケースも増えています。慢性疾患の増加とそれに伴うバイオ医薬品研究の急増が、治療用タンパク質、ペプチド、核酸の分析におけるCEの採用にさらに拍車をかけています。マイクロチップベースのCE、自動ハイスループット・システム、新しい分離モードの開発などの技術革新も、様々な分野でCEの有用性を拡大しています。CEは溶媒消費量が少なく、環境負荷の低減を目指すグリーンケミストリーの取り組みに合致しています。また、環境試験や食品安全などの分野でポータブルで使い勝手の良い分析装置への需要が高まっていることも、CEベースのシステムが現場分析用のコンパクトで信頼性の高いソリューションを提供することから、市場の成長に寄与しています。このような多様な成長促進要因によって、キャピラリー電気泳動市場は変貌を遂げ、科学研究や産業アプリケーションの進化するニーズに対応し続けることで、力強い拡大が見込まれています。

セグメント

エンドユーザー（学術機関およびCRO、製薬会社およびバイオテクノロジー企業、その他のエンドユーザー）

調査対象企業の例

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Helena Laboratories Corp.
  • Lumex Instruments
  • PerkinElmer Inc.
  • Promega Corp.
  • QIAGEN NV
  • SEBIA SA
  • Thermo Fisher Scientific Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17709

Global Capillary Electrophoresis Market to Reach US$1.5 Billion by 2030

The global market for Capillary Electrophoresis estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Academic Institutes & CROs, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$747.2 Million by the end of the analysis period. Growth in the Pharma & Biotech Companies segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$273.9 Million While China is Forecast to Grow at 9.5% CAGR

The Capillary Electrophoresis market in the U.S. is estimated at US$273.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$364.3 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Capillary Electrophoresis Market - Key Trends and Drivers Summarized

What Makes Capillary Electrophoresis a Vital Tool in Modern Analytical Chemistry?

Capillary Electrophoresis (CE) is a powerful analytical technique used to separate ionic species based on their size-to-charge ratio, using an electric field applied across a narrow capillary tube filled with an electrolyte solution. The method leverages the principles of electrophoresis, where charged molecules migrate through the capillary at different velocities depending on their charge, size, and the viscosity of the medium. CE is widely utilized for the separation and analysis of biomolecules such as proteins, nucleic acids, and peptides, as well as small molecules like pharmaceuticals and metabolites. The narrow capillary used in CE, typically made of fused silica, allows for efficient heat dissipation even at high voltages, resulting in sharper peaks and improved resolution compared to traditional gel electrophoresis. Furthermore, various modes of CE, such as capillary zone electrophoresis (CZE), micellar electrokinetic chromatography (MEKC), and capillary gel electrophoresis (CGE), allow for a broad range of applications tailored to specific analytical needs. The high separation efficiency, minimal sample volume requirements, and rapid analysis time make CE an ideal tool for both research and clinical settings. It is particularly valuable in the pharmaceutical and biotechnology industries for purity testing, quality control, and the analysis of complex biological samples. As such, capillary electrophoresis has become a cornerstone technique in modern analytical chemistry, providing precise and reproducible results across a variety of disciplines.

What Technological Breakthroughs Are Redefining the Potential of Capillary Electrophoresis?

Technological advancements have significantly expanded the capabilities and applications of capillary electrophoresis, enhancing its sensitivity, automation, and integration with other analytical methods. One of the most impactful developments is the coupling of CE with mass spectrometry (CE-MS), which combines the high-resolution separation power of CE with the mass-based identification capabilities of MS. This hybrid technique allows for detailed structural elucidation of complex biomolecules, such as proteins and oligonucleotides, providing both quantitative and qualitative data in a single analysis. The use of advanced detection systems, such as laser-induced fluorescence (LIF) and UV-vis detectors, has also improved the sensitivity of CE, enabling the detection of low-abundance analytes with high specificity. Automation has been another key area of innovation, with modern CE instruments featuring automated sample handling, capillary rinsing, and data acquisition, reducing the risk of human error and increasing throughput. Additionally, the development of microchip-based CE (MCE) has opened new avenues for miniaturization and high-throughput analysis. These microfluidic platforms, often referred to as "lab-on-a-chip" systems, integrate CE on a small-scale chip, allowing for rapid, parallel analysis with minimal reagent consumption and sample volumes. Another significant advancement is the use of coated capillaries and novel electrolyte formulations that minimize issues such as analyte adsorption and peak broadening, thus enhancing reproducibility and robustness. Furthermore, the emergence of new separation modes, such as chiral CE for the analysis of enantiomers and affinity CE for studying biomolecular interactions, has broadened the scope of CE applications. These technological enhancements have transformed CE into a versatile, high-performance tool for a wide range of scientific fields, from pharmaceutical research to environmental testing.

How Are Changing Research Priorities and Industry Demands Influencing the Capillary Electrophoresis Market?

The capillary electrophoresis market is being shaped by shifting research priorities, growing regulatory demands, and the increasing need for high-resolution, high-throughput analytical techniques in both academia and industry. The expanding scope of proteomics, genomics, and metabolomics research has driven a surge in demand for CE as a tool for the separation and analysis of complex biological samples. Researchers require techniques that offer high sensitivity and specificity, as well as the ability to separate minute sample volumes, making CE a preferred choice for analyzing protein isoforms, DNA fragments, and small metabolites. In the pharmaceutical industry, CE has gained prominence due to its ability to accurately assess drug purity, separate chiral compounds, and profile impurities, which are critical parameters for compliance with stringent regulatory requirements set by agencies like the FDA and EMA. Additionally, the growing emphasis on biopharmaceuticals, such as monoclonal antibodies and gene therapies, has spurred interest in CE for characterizing biologics and ensuring product quality and consistency. Another driving factor is the need for robust, reproducible analytical methods that can be seamlessly integrated into automated workflows, reducing time-to-market and increasing laboratory productivity. The adoption of CE in clinical diagnostics is also rising, particularly for the analysis of hemoglobin variants and detection of genetic disorders, reflecting its expanding role beyond traditional research applications. Furthermore, the trend towards green chemistry and sustainable laboratory practices is boosting the appeal of CE, as it typically requires less organic solvent and generates less waste compared to conventional chromatographic methods. As industry needs evolve towards more precise, rapid, and environmentally friendly analytical solutions, capillary electrophoresis is emerging as a key technology that aligns well with these requirements.

Which Key Factors Are Driving the Rapid Growth of the Capillary Electrophoresis Market?

The growth in the capillary electrophoresis market is driven by several critical factors, including the increasing demand for high-resolution analytical techniques, advancements in CE-MS technology, and the rising need for efficient biomolecule characterization in pharmaceutical and biotechnology sectors. The heightened focus on proteomics, genomics, and personalized medicine has spurred the need for sophisticated analytical tools capable of separating and identifying complex biological mixtures with high accuracy. This has positioned CE as an essential technique for laboratories engaged in cutting-edge research and clinical applications. The integration of CE with mass spectrometry (CE-MS) has been a major growth catalyst, providing enhanced sensitivity and comprehensive molecular profiling capabilities that are invaluable for drug development, biomarker discovery, and forensic analysis. Additionally, regulatory agencies have increasingly endorsed CE for quality control and compliance testing, particularly in the pharmaceutical industry, where it is used to ensure the purity and stability of drug products. The rising prevalence of chronic diseases and the consequent surge in biopharmaceutical research have further fueled the adoption of CE for the analysis of therapeutic proteins, peptides, and nucleic acids. Technological innovations such as microchip-based CE, automated high-throughput systems, and the development of novel separation modes are also expanding the utility of CE across various fields. Another significant driver is the growing emphasis on sustainable laboratory practices, as CE offers a low solvent consumption profile, aligning with green chemistry initiatives aimed at reducing environmental impact. The increasing demand for portable and user-friendly analytical devices in sectors like environmental testing and food safety is also contributing to market growth, as CE-based systems offer compact, reliable solutions for on-site analysis. These diverse growth drivers are transforming the capillary electrophoresis market, positioning it for robust expansion as it continues to meet the evolving needs of scientific research and industry applications.

SCOPE OF STUDY:

The report analyzes the Capillary Electrophoresis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Academic Institutes & CROs, Pharma & Biotech Companies, Other End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 12 Featured) -

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Helena Laboratories Corp.
  • Lumex Instruments
  • PerkinElmer Inc.
  • Promega Corp.
  • QIAGEN NV
  • SEBIA SA
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Capillary Electrophoresis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Resolution Separation Techniques Throws the Spotlight on Capillary Electrophoresis
    • Increasing Adoption in Biopharmaceutical Research Propels Market Growth
    • Advancements in Microfluidic Technologies Strengthen the Business Case for Capillary Electrophoresis
    • Expanding Use in Genetic Analysis and DNA Sequencing Generates Demand for CE Systems
    • Growing Emphasis on Analytical Accuracy and Sensitivity Drives Adoption Across Clinical Laboratories
    • Trend Toward Personalized Medicine Expands Addressable Market for Capillary Electrophoresis
    • Here's the Story: Rising Focus on Protein Characterization Sustains Market Growth in Proteomics
    • Innovations in Automated and High-Throughput Systems Propel Interest in CE for Large-Scale Studies
    • Rising Utilization in Food & Beverage Testing Creates New Opportunities in Quality Control
    • Growing Application in Environmental Testing Drives Market Penetration in Non-Traditional Sectors
    • Trend Toward Miniaturization Fuels Adoption of Portable and Field-Deployable CE Systems
    • Emerging Use of CE in Forensic Science Accelerates Adoption for DNA and Biomarker Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Capillary Electrophoresis Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Capillary Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Academic Institutes & CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Academic Institutes & CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Academic Institutes & CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Capillary Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Capillary Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Capillary Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Capillary Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Capillary Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Capillary Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Capillary Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Capillary Electrophoresis by End-Use - Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Capillary Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & CROs, Pharma & Biotech Companies and Other End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION